CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 8, 2022 · earnings

FULC earnings: a positive outcome, +15.0%

On November 8, 2022, Fulcrum Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +15.0% in the window around the event. It had already run -27.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$5.61
1d before
$6.45
Event day
$6.95
1d after
$7.14
5d after

Pre-catalyst setup

-27.2%
30-day run-up
9886%
30-day volatility
0.6×
volume spike